| WO2008051889 | | | | may also be flexible and capable of being attached to |
| Pellets containing an analgesic uniformly dispersed in a | | | | a patient without interfering with the patient's daily |
| lipid carrier such as cholesterol mixed with fatty acid | | | | routine. The phototherapy bandage may easily |
| esters, can be used to provide long term pain relief. 5 | | | | conform to the curves of a patient and may come in |
| mg cholesterol-tryglyceride- buprenorphine pellets | | | | a variety of exterior shapes and sizes. |
| released the majority of drug in 24-48 hours after | | | | WO2008021404 |
| implant and provide clinically significant plasma levels | | | | A composition providing cobalamine, cobalamine |
| of analgesia in mice for 3-9 days. Blood levels of | | | | subtype or cobalamine analog as an effective agent |
| analgesia peak at day-1 and are substantially | | | | for topical or transdermal administration to alleviate |
| complete by day-5 depending on the level of | | | | pain associated with a generalized or focal peripheral |
| buprenorphine. These results demonstrate that post | | | | neuropathic condition, such as carpal tunnel syndrome. |
| surgical implants provide clinically significant levels of | | | | Pain relief compositions for use in complementary |
| analgesia in the 24-48 hour period following surgery | | | | therapy are also provided. |
| and thus obviate the time consuming, expensive, and | | | | US2007276457 |
| high-risk need to inject mice post surgery. The pellets | | | | An infrared heating device and therapy for lower |
| are safe and easy to use. Placed in the surgical | | | | back pain includes a belt fastenable around a user so |
| wound at the end of surgery, they provide 2-3 days | | | | that the belt is overlaying at least a portion of a |
| of analgesia and obviate the need for subsequent | | | | lumbar region of the user. An infrared emitting |
| handling of the animal for pain therapy. The implants | | | | element is adjustably positionable between the belt |
| have no detectable effect on mouse behavior, | | | | and at a selected area of the user's lumbar region |
| hematology, or liver chemistry. The unexpected | | | | where a user desires pain relief therapy. A portable |
| release kinetics of the 5 mg pellet provides an ideal | | | | power supply is attachable to the belt and electrically |
| implant for post surgical analgesia. These implants | | | | connectable to the infrared emitting element so that |
| solve a significant problem facing scientists who use | | | | the user can receive infrared therapy at specific |
| rodents in research and abide by international of | | | | selected areas of the lower back while moving, |
| animal welfare. | | | | standing, sitting, reclining or sleeping. |
| US2008058689 | | | | US2007255187 |
| A phototherapy bandage capable of providing | | | | A device for providing therapy to a user including |
| radiation to a localized area of a patient for | | | | vibration and temperature modulation. The device |
| accelerating would healing and pain relief, | | | | provides mobile temperature modulation capabilities, |
| photodynamic therapy, and for aesthetic applications. | | | | mobile vibration capabilities, or a combination of the |
| The phototherapy bandage may include a flexible light | | | | two. The device provides advantages to a person or |
| source that is continuous across the bandage for | | | | animal including the ability to utilize the device in a |
| providing a selected light, such as a visible light, a | | | | hands-free manner. The device may also provide, |
| near-infrared light, or other light, having substantially | | | | under certain circumstances, pain relief or healing |
| similar intensity across the bandage. The bandage | | | | therapy to a person or animal. |